Clinical Trial Update: An Open Label Extension Study of Monepantel in Individuals With Motor Neurone Disease [Phase 1]

View source ↗

Summary

Open-label extension Phase 1 trial of Monepantel in individuals with motor neuron disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motor Neuron Disease

Drugs mentioned

• Monepantel (monepantel)

Snippet

Sponsor: Neurizon Therapeutics Limited | Conditions: Motor Neuron Disease | Phase 1 | Status: COMPLETED